For those interested in “mass tort” issues, well worth reading is today’s National Law Journal article regarding the recent wave of manufacturing defect product liability claims arising from drugs manufactured in China. The interesting points discussed include whether or how federal preemption principles will apply, and some aspects of claiming against Chinese entities. Not mentioned in the article are other interesting issues. For example, down the line, these suits could pr